Changes

Although allergic reaction from supplementation is possible, there is no known toxicity associated with high doses of the phylloquinone (vitamin K1) or menaquinone (vitamin K2) forms of vitamin K and therefore no tolerable upper intake level (UL) has been set.Blood clotting (coagulation) studies in humans using 45 mg per day of vitamin K2 (as MK4)[25] and even up to 135 mg/day (45 mg three times daily) of K2 (as MK4),[50] showed no increase in blood clot risk. Even doses in rats as high as 250 mg/kg body weight did not alter the tendency for blood-clot formation to occur.However, * a synthetic SYNTHETIC form of vitamin K, vitamin K3 (menadione), is demonstrably toxic. In fact, the FDA has banned this synthetic form of the vitamin from over-the-counter supplements because large doses have been shown to cause allergic reactions, hemolytic anemia, and cytotoxicity in liver cells, formation of radicals from enzymes of leukocytes, weakens the immune system, mutagenic effects, damage to the natural vitamin K cycle, hemolytic anemia and hyperbilirubinemia, disturbing levels of calcium ions, vomiting, albuminuria, irritation of skin and mucous membranes, allergic reactions, eczema and unlike natural vitamin K - it builds up in tissue.[edit]* Drug interactions Interactions : Phylloquinone (K1)or menaquinone (K2) are capable of blocking the blood thinning action of anticoagulants like warfarin, which work by interfering with the action of vitamin K. They also reverse the tendency of these drugs to cause arterial calcification in the long term.